Oral activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice.
about
Temporal aspects of the action of ASA404 (vadimezan; DMXAA).The development of the tumor vascular-disrupting agent ASA404 (vadimezan, DMXAA): current status and future opportunities.The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice.Preliminary Evidence That High-Dose Vitamin C has a Vascular Disrupting Action in Mice.
P2860
Oral activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Oral activity and pharmacokine ...... 4-acetic acid (DMXAA) in mice.
@en
Oral activity and pharmacokine ...... 4-acetic acid (DMXAA) in mice.
@nl
type
label
Oral activity and pharmacokine ...... 4-acetic acid (DMXAA) in mice.
@en
Oral activity and pharmacokine ...... 4-acetic acid (DMXAA) in mice.
@nl
prefLabel
Oral activity and pharmacokine ...... 4-acetic acid (DMXAA) in mice.
@en
Oral activity and pharmacokine ...... 4-acetic acid (DMXAA) in mice.
@nl
P2093
P1476
Oral activity and pharmacokine ...... 4-acetic acid (DMXAA) in mice.
@en
P2093
Bruce C Baguley
Lai-Ming Ching
Liangli Zhao
Philip Kestell
P2888
P356
10.1007/S00280-001-0377-3
P577
2002-01-01T00:00:00Z
P6179
1026444115